Gene Therapy Leaves a Vicious Cycle

Gene Therapy Leaves a Vicious Cycle Reena Goswami1, Gayatri Subramanian2, Liliya Silayeva1, Isabelle Newkirk1, Deborah Doctor1, Karan Chawla2, Saurabh Chattopadhyay2, Dhyan Chandra3, Nageswararao Chilukuri1 and Venkaiah Betapudi1,4* 1Neuroscience Branch, Research Division, United States Army Medical Research Institute of Chemical Defense, Aberdeen, MD, United States 2Department of Medical Microbiology and Immunology, University of Toledo College of Medicine and Life Sciences, Toledo, OH, United States 3Roswell Park Comprehensive Cancer Center, Buffalo, NY, United States 4Department of Physiology and Biophysics, Case Western Reserve University, Cleveland, OH, United States The human genetic code encrypted in thousands of genes holds the secret for synthesis of proteins that drive all biological processes necessary for normal life and death. Though the genetic ciphering remains unchanged through generations, some genes get disrupted, deleted and or mutated, manifesting diseases, and or disorders. Current treatment options—chemotherapy, protein therapy, radiotherapy, and surgery available for no more than 500 diseases—neither cure nor prevent genetic errors but often cause many side effects. However, gene therapy, colloquially called “living drug,” provides a one-time treatment option by rewriting or fixing errors in the natural genetic ciphering. Since gene therapy is predominantly a viral vector-based medicine, it has met with a fair bit of ...
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research

Related Links:

This study aimed to assess the relative safety and short-term efficacy of drug-eluting bead transarterial chemoembolization (DEB-TACE) and conventional transarterial chemoembolization (c-TACE) for treating peculiar anatomical sites of gastric cancer liver metastasis. MATERIAL AND METHODS Of the 68 patients with gastric cancer liver metastases confirmed by imaging and pathology, 35 were treated with DEB-TACE and 33 with c-TACE. The DEB-TACE group comprised 26 males and 9 females aged 28-75 years (56.8±6.3), and the c-TACE group included 19 males and 14 females aged 33-77 (60.2±9.4) years. Liver functions of th...
Source: Medical Science Monitor - Category: Research Tags: Med Sci Monit Source Type: research
CONCLUSIONS The network pharmacology analysis reveals the molecular biological mechanism of Artemisia annua anti-NSCLC via multiple active components, multi-channels, and multi-targets. This suggests that Artemisia annua might be developed as a promising anti-NSCLC drug. PMID: 32474568 [PubMed - in process]
Source: Medical Science Monitor - Category: Research Tags: Med Sci Monit Source Type: research
Severe acute respiratory syndrome coronavirus 2 (SARS–CoV-2), the cause of coronavirus disease 2019 (COVID-19), has spurred a global health crisis. To date, there are no proven options for prophylaxis for those who have been exposed to SARS–CoV-2, nor therapy for those who develop COVID-19. Immune (i.e., “convalescent”) plasma refers to plasma that is collected from individuals following resolution of infection and development of antibodies. Passive antibody administration through transfusion of convalescent plasma may offer the only short-term strategy for conferring immediate immunity to susceptib...
Source: Journal of Clinical Investigation - Category: Biomedical Science Authors: Source Type: research
Muscular dystrophies are debilitating disorders that result in progressive weakness and degeneration of skeletal muscle. Although the genetic mutations and clinical abnormalities of a variety of neuromuscular diseases are well known, no curative therapies have been developed to date. The advent of genome editing technology provides new opportunities to correct the underlying mutations responsible for many monogenic neuromuscular diseases. For example, Duchenne muscular dystrophy, which is caused by mutations in the dystrophin gene, has been successfully corrected in mice, dogs, and human cells through CRISPR/Cas9 editing. ...
Source: Journal of Clinical Investigation - Category: Biomedical Science Authors: Source Type: research
New J. Chem., 2020, Accepted Manuscript DOI: 10.1039/D0NJ01814G, PaperGurpreet Kaur, Monika Chaudhary, Kailash C Jena, Narinder Singh Abstract Environmental contamination due to increase in drug level is touching its alarming stage. There is an array of drugs such as antibiotics, antidepressants, analgesics, cancer chemotherapy drugs etc which... The content of this RSS Feed (c) The Royal Society of Chemistry
Source: RSC - New J. Chem. latest articles - Category: Chemistry Authors: Source Type: research
Analyst, 2020, Advance Article DOI: 10.1039/D0AN00627K, PaperJun Liu, Cheng Cao We propose a novel GSH-generating prodrug to be used with a sulfonamide-induced “integrative” platform for selective cancer therapy. To cite this article before page numbers are assigned, use the DOI form of citation above. The content of this RSS Feed (c) The Royal Society of Chemistry
Source: RSC - Analyst latest articles - Category: Chemistry Authors: Source Type: research
Dr Fauci says he hasn ’t spoken to Trump in two weeks; New Zealand to consider easing restrictions earlier than planned; Mexico deaths pass 10,000. Follow the latest updatesSingapore reopens schoolsUK: Critics round on No 10 over ‘ridiculous’ rules for 14-day quarantineAustralia coronavirus updates – liveCoronavirus latest: at a glanceSee all our coronavirus coverage6.46amBSTTheAssociated Pressis carrying a report that says Chinese officials sat on releasing the genetic map, or genome, of the coronavirus for over a week after multiple government labs had fully decoded it, not sharing details key to ...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Coronavirus outbreak World news Infectious diseases Science Microbiology Medical research UK news US news Australia news Source Type: news
Publication date: Available online 31 May 2020Source: Environmental Toxicology and PharmacologyAuthor(s): Badmus O. Olufunto, Njan Anoka, Ologe M. Olufunmilayo, Olatunji A. Lawrence
Source: Environmental Toxicology and Pharmacology - Category: Environmental Health Source Type: research
His group will study how abnormal calcium signals may contribute to human diseases such as allergies and asthma. (read more)
Source: Environmental Factor - NIEHS Newsletter - Category: Environmental Health Source Type: news
Emmie de Wit joins TWiV to explain her work on the pathogenesis of infection with SARS-CoV-2 in rhesus macaques, including studies on remdesivir and vaccine candidate. Hosts: Vincent Racaniello, Rich Condit, and Brianne Barker Guest: Emmie de Wit Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Respiratory disease in macaques inoculated with SARS-CoV-2 (Nature) Clinical benefit of remdesivir in SARS-CoV-2 infected macaques (bioRxiv) Remdesivir for MERS-CoV infection in macaques (PNAS) ChAdOX1 vaccination for SARS-CoV-2 in macaques ...
Source: This Week in Virology - MP3 Edition - Category: Virology Authors: Source Type: podcasts
More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Adenoidectomy | Adenoids | Adenoviruses | Allergy & Immunology | Anemia | Australia Health | Autoimmune Disease | Avastin | Back Pain | Biotechnology | Bird Flu | Blindness | Bone Marrow Transplant | Brain | Brain Cancers | Brain Tumor | Brazil Health | Bronchitis | Calcium | Canada Health | Cancer | Cancer & Oncology | Cancer Vaccines | Carcinoma | Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Centers for Disease Control and Prevention (CDC) | Chemistry | Chemotherapy | Child Development | Children | Chile Health | China Health | Clinical Trials | Cold Sores | Colon Cancer | Colorectal Cancer | Common Cold | Conjunctivitis | Cystic Fibrosis | Cytomegalovirus | Databases & Libraries | Depression | Diabetes | Diabetes Type 1 | Ebola | Ebola Vaccine | Enbrel | Encephalitis | Endocrinology | Epithelial Cancer | European Medicines Agency (EMA) | Eye Cancers | Fish | Food and Drug Administration (FDA) | Funding | Gastroschisis Repair | Gene Therapy | Genetics | Genital Herpes | Glioma | Grants | Haemophilia | Head and Neck Cancer | Heart | Heart Transplant | Hematology | Hemophilia | Hepatocellular Carcinoma | Herceptin | Herpes | HNSCC | Hodgkin's Disease | Hormones | Humira | Immunotherapy | Infectious Diseases | Japan Health | Kidney Stones | Kidney Transplant | Kidney Transplantation | Leukemia | Leukodystrophies | Liver | Liver Cancer | Liver Transplant | Lucentis | Lymphoma | Marketing | MCATs | Measles | Measles Vaccine | Medical Ethics | Melanoma | Microbiology | Motor Neurone Disease | Muscular Dystrophy | Nanotechnology | Neurology | Neuroscience | Neurosurgery | Non-Hodgkin's Lymphoma | Opthalmology | Oral Cancer | Ovarian Cancer | Ovaries | Pain | Pain Management | Pancreas | Pancreatic Cancer | Parvovirus | Philippines Health | Physiology | Pneomococcal Vaccine | Pneumonia | Primary CNS Lymphoma | Prostate Cancer | Ranibizumab Injection | Rare Diseases | Reflex Sympathetic Dystrophy | Remicade | Research | Retinoblastoma | Rituxan | Russia Health | Sarcomas | Science | Skin Cancer | Sodium | Sore Throat | South Korea Health | Spinal Muscular Atrophy | Squamous Cell Carcinoma | Stem Cell Therapy | Stem Cells | Study | Suicide | Switzerland Health | Toxicology | Transplant Surgery | Transplants | University of Pennsylvania | Urology & Nephrology | USA Health | Vaccines | Varicella-Zoster Virus Vaccine | Veterinary Vaccinations | Vitamin A | von Willebrand Disease | Zinc